ACG Inspection (ACGI) is partnering with CertiRx Corp., d.b.a. Verinetics, for further enhancing its traceability and authenticity offerings for the track-and-trace industry. With this partnership, ACGI seeks to implement an add-on security layer to provide Multi-Factor Authentication to the end consumer.
Multi-factor authentication is a security system that requires more than one method of authentication from independent categories of credentials to verify an identity. Verinetics’ patent-protected, next-generation software product TraxSecur is used for detecting and deterring fraud in the supply chain. Using TraxSecur as a security mark provides intelligent authentication, linked with serialization data.
Falsified medications are one of the major problems faced by the global pharmaceutical industry. As per the World Health Organization (WHO), an estimated one in 10 medical products in low- and middle-income countries is substandard or falsified. On World Anti-Counterfeiting Day, June 6, 2018, ACGI says it “waged a war against falsified medicines.” This campaign emphasized the effects of substandard or falsified medicines on the human population and the global pharmaceutical industry with the message "Get the Fake Drugs Off the Market.”
Ettore Cucchetti, ACGI’s CEO says, “With the increasing threat of falsified medicines in the pharmaceutical supply chain and regulations mandating companies to deploy strategies such as serialization and to have greater awareness, there is a need for innovative and effective solutions for product authentication, [and] track-and-trace and supply chain integrity. We strongly believe that our association with Verinetics is a step towards nipping the problem that is grappling the industry today. With the introduction of TraxSecur with track-and-trace regulatory compliance will help us to safeguard the existing supply chain. The association will equip consumers with product authentication and ensure genuine products to consumers. Also, it will bring the consumer closer to the pharmaceutical companies, providing first-hand feedback about the products.”
Dr. Tom Mercolino, CEO of Verinetics, says, “Wherever high-value products have health and safety risks, companies are investing to protect their customers through supply chain security solutions like serialization and blockchain. ACGI has the vision to bring TraxSecur to the pharmaceutical market and deliver its unique benefits as a secure link between items in the physical world and data about those items being tracked in serialization and blockchain systems. We also applaud ACGI for recognizing the importance of TraxSecur’s multilayered approach for deterring supply chain frauds with overt feature, increasing fraud detection and enforcement effectiveness through its covert features, and how its implementation will increase patient trust in their customers’ products.”